📰 Peter Bains News
Page 2 - Peter Bains News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Bains. Real-time updates on events, politics, business and more.
September 20, 2023
"Peter, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon Group because he has basically played a very key role in Syngene. Through Syngene, he has understood the entire Biocon business very well."
September 20, 2023
Stocks to watch: Shares of firms like HDFC Bank, RR Kabel, Tata Motors, Cipla, Coal India, Biocon, and others will be in focus on Wednesday's trade.
September 19, 2023
The short build-up was seen in 79 stocks. These included Ipca Laboratories, Delta Corp, SBI Card, NALCO, and Vodafone Idea. An increase in OI along with a fall in price points to a build-up of short positions.
September 18, 2023
He has over 30 years of global experience in strategic and operational leadership, including at board, CEO and senior corporate levels. He served as CEO and on the Board of Syngene International Ltd, a subsidiary of the company, for almost 6 years from 2010, and led the company to its successful public listing in 2015, Biocon said.
September 18, 2023
Mazumdar-Shaw said Peter has a unique fit and profile for the role having both extensive global leadership experience and success across the biopharmaceutical field and a comprehensive understanding of the Biocon Group, having led Syngene for 5 years, taking it through its very successful IPO in 2015
September 18, 2023
'Peter has a comprehensive understanding of the Biocon Group, having led Syngene for 5 years, taking it through its very successful IPO in 2015,' says Mazumdar-Shaw
September 18, 2023
Biocon appoints Peter Bains as group CEO, effective immediately. Bains has over 30 years of global experience in leadership roles.
May 23, 2023
A Lanarkshire-based biotech firm is strengthening its presence in the animal healthcare market, where it sees strong potential, by inking a tie-up that it says will progress its product to treat a condition causing itchy skin in dogs.
April 27, 2023
A Scottish biotechnology company specialising in anti-viral treatments has flagged its intention to raise further investment ahead of a possible…
April 26, 2023
ILC's Alfacyte product has potential to become a game-changing antiviral treatment in the ongoing global fight against Covid-19 Scottish biotech ICL Therapeutics has set its sights on a Series A round